Back to mobile site

Roth Capital Upgrades Cempra, Inc. (CEMP) to Buy Ahead Of Bone Data In 2017

February 27, 2017 9:21 AM EST Send to a Friend
Roth Capital upgraded Cempra, Inc. (NASDAQ: CEMP) from Neutral to Buy with a price target of $8.00.Analyst Michael Higgins comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login